The National Institute for Excellence in Health and Care (NICE) said new findings and treatments like the drug Omacor for patients with heart attack (myocardial infarction) have reduced the effects of omega-3 consumption through food or supplements.
“NICE no longer recommends eating oily fish or eating omega-3 fatty acid capsules or foods supplemented with omega-3 fatty acids specifically to prevent further heart attacks,” said NICE.
“People who have had a heart attack should still eat the Mediterranean way – with more bread, fruit, vegetables and fish, less meat, as well as butter and cheese, which are replaced by products based on vegetable oil.”
NICE’s previous pro-omega-3 guidelines recommended that “patients consume seven grams of omega-3 per week from 2 to 4 servings of fatty fish or a recipe from Omacor 1 gram / day”.
The revision takes place because this week three Omega-3-EPA-DHA claims related to heart health were added to EU law books under Article 13 of the strict Regulation on Nutrition and Health Claims (NHCR).
“Given the current scientific knowledge, the unfortunate decision of the National Institute for Excellence in Health and Care (NICE) to withdraw the O-3 recommendation for patients with post-myocardial infarction is disappointing and somewhat wrong,” said the Global Organization for EPA and DHA Omega-3s (GOED) VP of Regulatory and Scientific Affairs, Harry Rice, PhD.
In the literature.
He said studies such as a cohort study recently published in the New England Journal of Medicine of more than 12,000 patients with multiple cardiovascular risk factors that found that omega-3 acids did not reduce cardiovascular mortality and morbidity have been implicated would have to.
“One of the biggest complaints about recent studies examining the effects of omega-3s on cardiovascular endpoints is that the studies are under-served as patients receive cutting-edge antihypertensive, antithrombotic, and lipid-modifying therapy.” Dr. Rice said.
“Essentially, omega-3s have no effect on cardiovascular outcomes like myocardial infarction. Rather, the investigators cannot power their studies sufficiently to determine an effect. “
Nice spoon of advice: Omega-3s won’t help heart attack patients on their own, but GOED said its reference data is obscured by other factors like drug use
“NICE, as a public body providing national guidelines and advice on improving health and social care, should look for cost-effective solutions with minimal side effects.”
He said the NICE Council hadn’t changed the body of evidence that health claims had been made under the tough EU system.
“Therefore, consumers should continue to take omega-3 heart health products.”